Investigating the Mechanisms of Hyporesponse to Antiplatelet Approaches

Hyporesponsiveness, or resistance, to antiplatelet therapy may be a major contributor to poorer outcomes among cardiac patients and may be attributed to an array of mechanisms—both modifiable and unmodifiable. Recent evidence has uncovered clinical, cellular, and genetic factors associated with hypo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Cardiol
Autores principales: Braunwald, Eugene, Angiolillo, Dominick, Bates, Eric, Berger, Peter B., Bhatt, Deepak, Cannon, Christopher P., Furman, Mark I., Gurbel, Paul, Michelson, Alan D., Peterson, Eric, Wiviott, Stephen
Formato: Artigo
Lenguaje:Inglês
Publicado: Wiley Periodicals, Inc. 2008
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6653508/
https://ncbi.nlm.nih.gov/pubmed/18481819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.20360
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares